Cargando…

In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms

Tumor cells may be eliminated by increasing their temperature. This is achieved via photothermal therapy (PTT) by penetrating the tumor tissue with near‐infrared light and converting light energy into heat using photothermal agents. Copper sulfide nanoparticles (CuS NPs) are commonly used as PTAs in...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jingwen, Li, Na, Wang, Jingjian, Liu, Zhe, Han, Yulong, Zeng, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582616/
https://www.ncbi.nlm.nih.gov/pubmed/37933283
http://dx.doi.org/10.1002/EXP.20220161
_version_ 1785122370861662208
author Ma, Jingwen
Li, Na
Wang, Jingjian
Liu, Zhe
Han, Yulong
Zeng, Yun
author_facet Ma, Jingwen
Li, Na
Wang, Jingjian
Liu, Zhe
Han, Yulong
Zeng, Yun
author_sort Ma, Jingwen
collection PubMed
description Tumor cells may be eliminated by increasing their temperature. This is achieved via photothermal therapy (PTT) by penetrating the tumor tissue with near‐infrared light and converting light energy into heat using photothermal agents. Copper sulfide nanoparticles (CuS NPs) are commonly used as PTAs in PTT. In this review, we aimed to discuss the synergism between tumor PTT with CuS NPs and other therapies such as chemotherapy, radiotherapy, dynamic therapies (photodynamic, chemodynamic, and sonodynamic therapy), immunotherapy, gene therapy, gas therapy, and magnetic hyperthermia. Furthermore, we summarized the results obtained with a combination of two treatments and at least two therapies, with PTT as one of the included therapies. Finally, we summarized the benefits and drawbacks of various therapeutic options and state of the art CuS‐based PTT and provided future directions for such therapies.
format Online
Article
Text
id pubmed-10582616
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-105826162023-11-05 In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms Ma, Jingwen Li, Na Wang, Jingjian Liu, Zhe Han, Yulong Zeng, Yun Exploration (Beijing) Reviews Tumor cells may be eliminated by increasing their temperature. This is achieved via photothermal therapy (PTT) by penetrating the tumor tissue with near‐infrared light and converting light energy into heat using photothermal agents. Copper sulfide nanoparticles (CuS NPs) are commonly used as PTAs in PTT. In this review, we aimed to discuss the synergism between tumor PTT with CuS NPs and other therapies such as chemotherapy, radiotherapy, dynamic therapies (photodynamic, chemodynamic, and sonodynamic therapy), immunotherapy, gene therapy, gas therapy, and magnetic hyperthermia. Furthermore, we summarized the results obtained with a combination of two treatments and at least two therapies, with PTT as one of the included therapies. Finally, we summarized the benefits and drawbacks of various therapeutic options and state of the art CuS‐based PTT and provided future directions for such therapies. John Wiley and Sons Inc. 2023-06-24 /pmc/articles/PMC10582616/ /pubmed/37933283 http://dx.doi.org/10.1002/EXP.20220161 Text en © 2023 The Authors. Exploration published by Henan University and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Reviews
Ma, Jingwen
Li, Na
Wang, Jingjian
Liu, Zhe
Han, Yulong
Zeng, Yun
In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms
title In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms
title_full In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms
title_fullStr In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms
title_full_unstemmed In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms
title_short In vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms
title_sort in vivo synergistic tumor therapies based on copper sulfide photothermal therapeutic nanoplatforms
topic Reviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582616/
https://www.ncbi.nlm.nih.gov/pubmed/37933283
http://dx.doi.org/10.1002/EXP.20220161
work_keys_str_mv AT majingwen invivosynergistictumortherapiesbasedoncoppersulfidephotothermaltherapeuticnanoplatforms
AT lina invivosynergistictumortherapiesbasedoncoppersulfidephotothermaltherapeuticnanoplatforms
AT wangjingjian invivosynergistictumortherapiesbasedoncoppersulfidephotothermaltherapeuticnanoplatforms
AT liuzhe invivosynergistictumortherapiesbasedoncoppersulfidephotothermaltherapeuticnanoplatforms
AT hanyulong invivosynergistictumortherapiesbasedoncoppersulfidephotothermaltherapeuticnanoplatforms
AT zengyun invivosynergistictumortherapiesbasedoncoppersulfidephotothermaltherapeuticnanoplatforms